Clinical trial · Observational
A Hierarchical Multi-modal AI Framework for Pathological and Genetic Subtyping of Lung Cancer Based on PET/CT Imaging
NCT07463300CI-TRIAL-00105187recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
PET/CT imaging and clinical information (age, gender, smoking history, family history of cancer, history of present illness, and several tumor biomarkers, etc.) were used to establish a hierarchical multi-modal AI framework for pathological and genetic subtyping of lung cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| PET imaging analysis, data mining, and AI model developing | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- Training Cohort
- description
- All patients underwent pre-treatment 18F-FDG PET/CT scan.
- interventionNames
- Other: PET imaging analysis, data mining, and AI model developing
- label
- Validation Cohort
- description
- All patients underwent pre-treatment 18F-FDG PET/CT scan.
- interventionNames
- Other: PET imaging analysis, data mining, and AI model developing
- label
- Test cohort
- description
- All patients underwent pre-treatment 18F-FDG PET/CT scan.
- interventionNames
- Other: PET imaging analysis, data mining, and AI model developing
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Newly diagnosed NSCLC confirmed pathologically * Age ≥18 y * Underwent pre-treatment 18F-FDG PET/CT scan * No prior anti-tumor treatments * No history of other malignancies Exclusion Criteria: ▪ Pure ground-glass nodules with no FDG uptake
References
Publications (0)
Data not yet available
No reference posted for this study.